Skip to content
2000
image of Recent Advancements in Nanosuspension-based Drug Delivery Systems: A Mini-Review from Concept to Applications

Abstract

Nanosuspensions have emerged as a promising drug delivery system for poorly water- soluble drugs, offering several advantages over traditional and other nanocarrier-based systems. Unlike liposomes or polymeric nanoparticles that encapsulate drugs, nanosuspensions are submicron colloidal dispersions consisting purely of drug particles stabilized by surfactants or polymers. This direct formulation enhances drug loading, increases dissolution rate, and improves oral and parenteral bioavailability. Various preparation techniques, including high-pressure homogenization, media milling, and precipitation methods, have been optimized for scalability and reproducibility. Recent research demonstrates the potential of nanosuspensions in targeted drug delivery, particularly in oncology, due to their ability to enhance tissue penetration and reduce off-target effects. This mini-review summarizes the fundamental principles, production techniques, physicochemical characterization, recent applications, limitations, and future directions in nanosuspension-based drug delivery, highlighting their unique advantages over other nanosystems.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/ddl/10.2174/0122103031404107250801141026
2025-08-07
2025-09-13

  • From This Site

    /content/journals/ddl/10.2174/0122103031404107250801141026
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Patil O. Patil I. Mane R. Randive D. Bhutkar M. Bhinge S.D. Formulation optimization and evaluation of Cefdinir nanosuspension using 23 Factorial design. J. Res. Pharm. 2018 22 1 257 268 10.12991/jrp.2018.101
    [Google Scholar]
  2. Chen H. Deng M. Xie L. Liu K. Zhang X. Li X. Preparation and characterization of quercetin nanosuspensions using gypenosides as novel stabilizers. J. Drug Deliv. Sci. Technol. 2022 67 102962 10.1016/j.jddst.2021.102962
    [Google Scholar]
  3. Agrawal Y.K. Patel V.R. Nanosuspension: An approach to enhance solubility of drugs. J. Adv. Pharm. Technol. Res. 2011 2 2 81 87 10.4103/2231‑4040.82950 22171298
    [Google Scholar]
  4. Sharma D.K. Recent advancements in nanoparticles for cancer treatment. Med. Oncol. 2025 42 3 72 10.1007/s12032‑025‑02609‑4 39928091
    [Google Scholar]
  5. Attari Z. Bhandari A. Jagadish P.C. Lewis S. Enhanced ex- vivo intestinal absorption of olmesartan medoxomil nanosuspension: Preparation by combinative technology. Saudi Pharm. J. 2016 24 1 57 63 10.1016/j.jsps.2015.03.008 26903769
    [Google Scholar]
  6. McGuckin M.B. Wang J. Ghanma R. Qin N. Palma S.D. Donnelly R.F. Paredes A.J. Nanocrystals as a master key to deliver hydrophobic drugs via multiple administration routes. J. Control. Release 2022 345 334 353 10.1016/j.jconrel.2022.03.012 35283257
    [Google Scholar]
  7. Saripilli R. Sharma D.K. Nanotechnology-based drug delivery system for the diagnosis and treatment of ovarian cancer. Discover Oncology 2025 16 1 422 10.1007/s12672‑025‑02062‑9 40155504
    [Google Scholar]
  8. Agarwal V. Bajpai M. Sharma A. Patented and approval scenario of nanopharmaceuticals with relevancy to biomedical application, manufacturing procedure and safety aspects. Recent Pat. Drug Deliv. Formul. 2018 12 1 40 52 10.2174/1872211312666180105114644 29303083
    [Google Scholar]
  9. Jayalakshmy R. Sreethu K.S. Nano-suspensions: A method for solubility enhancement. J. Med. Pharm. Allied Sci. 2021 10 3 2763 2761 10.22270/jmpas.v10i3.1070
    [Google Scholar]
  10. Patravale V.B. Date A.A. Kulkarni R.M. Nanosuspensions: A promising drug delivery strategy. J. Pharm. Pharmacol. 2004 56 7 827 840 10.1211/0022357023691 15233860
    [Google Scholar]
  11. Sharma D.K. Pattnaik G. Behera A. Recent developments in nanoparticles for the treatment of diabetes. J. Drug Target. 2023 31 9 908 919 10.1080/1061186X.2023.2261077 37725445
    [Google Scholar]
  12. Rana A. Adhikary M. Singh P.K. Das B.C. Bhatnagar S. “Smart” drug delivery: A window to future of translational medicine. Front Chem. 2023 10 1095598 10.3389/fchem.2022.1095598 36688039
    [Google Scholar]
  13. Peters K. Leitzke S. Diederichs J.E. Borner K. Hahn H. Müller R.H. Ehlers S. Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection. J. Antimicrob. Chemother. 2000 45 1 77 83 10.1093/jac/45.1.77 10629016
    [Google Scholar]
  14. Aldeeb M. Wilar G. Suhandi C. Elamin K. Wathoni N. Nanosuspension-based drug delivery systems for topical applications. Int. J. Nanomedicine 2024 19 825 844 10.2147/IJN.S447429 38293608
    [Google Scholar]
  15. Pradeep K. Kamal Kumari B. Versatility of nanosuspension formulation in various drug delivery systems: A brief review. Adv. Pharm. J. 2020 5 2 36 46 10.31024/apj.2020.5.2.1
    [Google Scholar]
  16. Moneghini M. Kikic I. Voinovich D. Perissutti B. Filipović- Grčić J. Processing of carbamazepine–PEG 4000 solid dispersions with supercritical carbon dioxide: Preparation, characterisation, and in vitro dissolution. Int. J. Pharm. 2001 222 1 129 138 10.1016/S0378‑5173(01)00711‑6 11404039
    [Google Scholar]
  17. Kipp J.E. Wong J.C.T. Doty M.J. Rebbeck C.L. Microprecipitation method for preparing submicron suspensions. 2003 U.S. Patent US6607784B2
  18. Kathpalia H. Juvekar S. Shidhaye S. Design and in vitro evaluation of atovaquone nanosuspension prepared by pH based and anti-solvent based precipitation method. Colloid Interface Sci. Commun. 2019 29 26 32 10.1016/j.colcom.2019.01.002
    [Google Scholar]
  19. Liversidge G.G. Cundy K.C. Bishop J.F. Zekai D.A.C. Surface modified drug nanoparticles. 1992 U.S. Patent US5145684A
  20. Watanabe T. Ohno I. Wakiyama N. Kusai A. Senna M. Stabilization of amorphous indomethacin by co-grinding in a ternary mixture. Int. J. Pharm. 2002 241 1 103 111 10.1016/S0378‑5173(02)00196‑5 12086726
    [Google Scholar]
  21. Zhang D. Tan T. Gao L. Zhao W. Wang P. Preparation of azithromycin nanosuspensions by high pressure homogenization and its physicochemical characteristics studies. Drug Dev. Ind. Pharm. 2007 33 5 569 575 10.1080/03639040600975147 17520449
    [Google Scholar]
  22. Kipp J.E. Wong J.C.T. Doty M.J. Werling J. Rebbeck C. Brynjelsen S. Method for preparing submicron particle suspensions. 2003 U.S. Patent US20030031719A1
  23. Sharma D.K. Current advancements in nanoparticles for vaccines and drug delivery for the treatment of tuberculosis. J. Microbiol. Methods 2025 232-234 107138 10.1016/j.mimet.2025.107138 40280241
    [Google Scholar]
  24. Young T.J. Mawson S. Johnston K.P. Henriksen I.B. Pace G.W. Mishra A.K. Rapid expansion from supercritical to aqueous solution to produce submicron suspensions of water-insoluble drugs. Biotechnol. Prog. 2000 16 3 402 407 10.1021/bp000032q 10835242
    [Google Scholar]
  25. Arunkumar N. Deecaraman M. Rani C. Nanosuspension technology and its applications in drug delivery. Asian J. Pharm. 2009 3 3 168 173 [AJP]. 10.4103/0973‑8398.56293
    [Google Scholar]
  26. Yang J.Z. Young A.L. Chiang P.C. Thurston A. Pretzer D.K. Fluticasone and budesonide nanosuspensions for pulmonary delivery: Preparation, characterization, and pharmacokinetic studies. J. Pharm. Sci. 2008 97 11 4869 4878 10.1002/jps.21380 18351635
    [Google Scholar]
  27. Thakkar H. Patel B. Thakkar S. Development and characterization of nanosuspensions of olmesartan medoxomil for bioavailability enhancement. J. Pharm. Bioallied Sci. 2011 3 3 426 434 10.4103/0975‑7406.84459 21966165
    [Google Scholar]
  28. Jacob S. Nair A.B. Shah J. Emerging role of nanosuspensions in drug delivery systems. Biomater. Res. 2020 24 1 3 10.1186/s40824‑020‑0184‑8 31969986
    [Google Scholar]
  29. Hanafy A. Spahnlangguth H. Vergnault G. Grenier P. Tubicgrozdanis M. Lenhardt T. Langguth P. Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug. Adv. Drug Deliv. Rev. 2007 59 6 419 426 10.1016/j.addr.2007.04.005 17566595
    [Google Scholar]
  30. Patel D. Zode S.S. Bansal A.K. Formulation aspects of intravenous nanosuspensions. Int. J. Pharm. 2020 586 119555 10.1016/j.ijpharm.2020.119555 32562654
    [Google Scholar]
  31. Merisko-Liversidge E. Liversidge G.G. Cooper E.R. Nanosizing: A formulation approach for poorly-water-soluble compounds. Eur. J. Pharm. Sci. 2003 18 2 113 120 10.1016/S0928‑0987(02)00251‑8 12594003
    [Google Scholar]
  32. Gupta H. Aqil M. Khar R.K. Ali A. Bhatnagar A. Mittal G. Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. Nanomedicine 2010 6 2 324 333 10.1016/j.nano.2009.10.004 19857606
    [Google Scholar]
  33. Pınar S.G. Oktay A.N. Karaküçük A.E. Çelebi N. Formulation strategies of nanosuspensions for various administration routes. Pharmaceutics 2023 15 5 1520 10.3390/pharmaceutics15051520 37242763
    [Google Scholar]
  34. Vitore J.G. Pagar S. Singh N. Karunakaran B. Salve S. Hatvate N. Rojekar S. Benival D. A comprehensive review of nanosuspension loaded microneedles: Fabrication methods, applications, and recent developments. J. Pharm. Investig. 2023 53 4 475 504 10.1007/s40005‑023‑00622‑1
    [Google Scholar]
  35. Liu Y. Xu H. Yan N. Tang Z. Wang Q. Research progress of ophthalmic preparations of immunosuppressants. Drug Deliv. 2023 30 1 2175925 10.1080/10717544.2023.2175925 36762580
    [Google Scholar]
  36. Kulkarni R. Fanse S. Burgess D.J. Mucoadhesive drug delivery systems: A promising noninvasive approach to bioavailability enhancement. Part II: Formulation considerations. Expert Opin. Drug Deliv. 2023 20 3 413 434 10.1080/17425247.2023.2181332 36803264
    [Google Scholar]
  37. Jacobs C. Müller R.H. Production and characterization of a budesonide nanosuspension for pulmonary administration. Pharm. Res. 2002 19 2 189 194 10.1023/A:1014276917363 11883646
    [Google Scholar]
  38. Rossi I. Sonvico F. McConville J.T. Rossi F. Fröhlich E. Zellnitz S. Rossi A. Del Favero E. Bettini R. Buttini F. Nebulized coenzyme Q 10 nanosuspensions: A versatile approach for pulmonary antioxidant therapy. Eur. J. Pharm. Sci. 2018 113 159 170 10.1016/j.ejps.2017.10.024 29066385
    [Google Scholar]
  39. Malamatari M. Somavarapu S. Taylor K.M.G. Buckton G. Solidification of nanosuspensions for the production of solid oral dosage forms and inhalable dry powders. Expert Opin. Drug Deliv. 2016 13 3 435 450 10.1517/17425247.2016.1142524 26764574
    [Google Scholar]
  40. Hernández-Trejo N. Kayser O. Steckel H. Müller R.H. Characterization of nebulized buparvaquone nanosuspensions—effect of nebulization technology. J. Drug Target. 2005 13 8-9 499 507 10.1080/10611860500353245 16332575
    [Google Scholar]
  41. Rabinow B. Kipp J. Papadopoulos P. Wong J. Glosson J. Gass J. Sun C.S. Wielgos T. White R. Cook C. Barker K. Wood K. Itraconazole IV nanosuspension enhances efficacy through altered pharmacokinetics in the rat. Int. J. Pharm. 2007 339 1-2 251 260 10.1016/j.ijpharm.2007.02.030 17398045
    [Google Scholar]
  42. Müller R.H. Jacobs C. Buparvaquone mucoadhesive nanosuspension: Preparation, optimisation and long-term stability. Int. J. Pharm. 2002 237 1-2 151 161 10.1016/S0378‑5173(02)00040‑6 11955813
    [Google Scholar]
  43. Lamprecht A. Schäfer U. Lehr C.M. Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa. Pharm. Res. 2001 18 6 788 793 10.1023/A:1011032328064 11474782
    [Google Scholar]
  44. Date A.A. Halpert G. Babu T. Ortiz J. Kanvinde P. Dimitrion P. Narayan J. Zierden H. Betageri K. Musmanno O. Wiegand A.A. Huang X. Gumber S. Hanes J. Ensign L.M. Mucus-penetrating budesonide nanosuspension enema for local treatment of inflammatory bowel disease. Biomaterials 2018 185 97 105 10.1016/j.biomaterials.2018.09.005 30236840
    [Google Scholar]
  45. Ma Y. Cong Z. Gao P. Wang Y. Nanosuspensions technology as a master key for nature products drug delivery and in vivo fate. Eur. J. Pharm. Sci. 2023 185 106425 10.1016/j.ejps.2023.106425 36934992
    [Google Scholar]
  46. Saha P. Kathuria H. Pandey M.M. Nose-to-brain delivery of rotigotine redispersible nanosuspension: in vitro and in vivo characterization. J. Drug Deliv. Sci. Technol. 2023 79 104049 10.1016/j.jddst.2022.104049
    [Google Scholar]
  47. Mehmood Y. Shahid H. Tahir M.A. Abbas M. Farooq U. Khan Z.M. Yousaf H. Uddin M.N. Kazi M. Remdesivir nanosuspension for potential nasal drug delivery: determination of pro-inflammatory interleukin IL-4 mRNA expression and industrial scale-up strategy. J. Nanopart. Res. 2023 25 7 129 10.1007/s11051‑023‑05784‑5
    [Google Scholar]
  48. Elbaz N.M. Tatham L.M. Owen A. Rannard S. McDonald T.O. Layer by layer self-assembly for coating a nanosuspension to modify drug release and stability for oral delivery. Food Hydrocoll. 2023 144 108908 10.1016/j.foodhyd.2023.108908
    [Google Scholar]
  49. Piao H. Kamiya N. Hirata A. Fujii T. Goto M. A novel solid-in-oil nanosuspension for transdermal delivery of diclofenac sodium. Pharm. Res. 2008 25 4 896 901 10.1007/s11095‑007‑9445‑7 17896098
    [Google Scholar]
  50. Lai F. Pireddu R. Corrias F. Fadda A.M. Valenti D. Pini E. Sinico C. Nanosuspension improves tretinoin photostability and delivery to the skin. Int. J. Pharm. 2013 458 1 104 109 10.1016/j.ijpharm.2013.10.007 24135683
    [Google Scholar]
  51. Sampathi S. Haribhau C.J. Kuchana V. Junnuthula V. Dyawanapelly S. Nanosuspension encapsulated chitosan-pectin microbeads as a novel delivery platform for enhancing oral bioavailability. Carbohydr. Polym. 2023 319 121177 10.1016/j.carbpol.2023.121177 37567693
    [Google Scholar]
  52. Goel S. Sachdeva M. Agarwal V. Nanosuspension technology: Recent patents on drug delivery and their characterizations. Recent Pat. Drug Deliv. Formul. 2019 13 2 91 104 10.2174/1872211313666190614151615 31203813
    [Google Scholar]
  53. Chen M.J. Hui H.W. Lee T. Kurtulik P. Surapaneni S. 2015 U.S. Patent US9023885B2
  54. Zhang J.C.N. Lurasidone nanosuspension and preparation method thereof. 2015 U.S. Patent CN104814926A
  55. Kablitz C. New treatment of fish with a nanosus pens ion of lufenuron or hexaflumuron. 2015 U.S. Patent US20150238446A1
  56. Shi S.C.N. Method of preparation of nanocrystals of simvastatin. 2016 C.N. Patent CN105315249
  57. Zhang L. Wu S. Li Z. Dong S. Feng J. Sun J. Liu L. Bian L.C.N. Method of developing celecoxib nanosuspension capsule. 2016 C.N. Patent CN105534947
  58. Mao S Guan J Helgerud T Zhang Y. WO Nanosuspension formulation. 2016 W.O. Patent WO2016081593Al
  59. Xu S. Zhu Y. Fan Q. Ou S. Liu X.C.N. Nanosuspension of tobramycin and dexamethasone and preparation method thereof. 2016 C.N. Patent CN105708844
  60. Gerusz V. Mouze C. Van F. Ameye D. Novel drug formulation. 2016 U.S. Patent US20160206577A1
  61. Bommagani M Bhowmick SB Kane P Dubey V. WO Method of preparing the nanoparticulate topical composition. 2016 W.O. WO2016135753Al
  62. Inghelbrecht S.K.K. Beirowski J.A. Gieseler H. Freeze dried drug nanosuspension. 2016 U.S. Patent US20160317534A1
  63. Chow D.S.L. Samant T.S. Tu S.M. Injectable diethylstilbestrol nanosuspension formulation. 2020 U.S. Patent US20200246278A1
  64. Werner B. JP Nanosuspensions containing particles and extracts of natural materials. 2020 J.P. Patent JP2020121974A
  65. Werner B. EP Nanosuspension of natural materials and preparation method thereof. 2021 E.P. Patent EP3102185B1
/content/journals/ddl/10.2174/0122103031404107250801141026
Loading
Recent Advancements in Nanosuspension-based Drug Delivery Systems: A Mini-Review from Concept to Applications
Bentham Science Publishers ; https://doi.org/10.2174/0122103031404107250801141026
/content/journals/ddl/10.2174/0122103031404107250801141026
/content/journals/ddl/10.2174/0122103031404107250801141026
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: bioavailability ; Nanosuspensions ; manufacturing techniques ; drug delivery ; solubility

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test